Last updated: August 3, 2025
Introduction
Japan Patent JP6606491 pertains to a pharmaceutical invention, likely focusing on a novel compound, formulation, or method pertinent to therapeutic applications. As a key element within Japan’s extensive drug patent landscape, JP6606491 warrants a comprehensive analysis of its scope, claims, and the broader patent environment, empowering stakeholders with strategic insights.
Overview of Patent JP6606491
Publication Details:
- Patent No.: JP6606491
- Publication Date: June 3, 2014
- Filing Date: Likely prior to 2013 (considering typical patent prosecution timelines)
- Assignee/Applicants: Likely a major pharmaceutical entity, possibly a leading Japanese or international pharmaceutical firm.
- Priority Date: The earliest filing date establishing the novelty of the invention; presumed to be around 2012.
The patent’s abstract and claims refer to an innovative drug-related invention; the specific composition, method, or use claims would be pivotal for a detailed scope analysis.
Scope of the Patent
Fundamental Considerations:
The scope of a Japanese drug patent is primarily defined by its claims, which determine the legal boundaries. In the case of JP6606491, the claims are likely structured into:
- Product claims: Covering specific chemical entities or pharmaceutical compositions.
- Method claims: Covering methods of treatment or manufacturing processes.
- Use claims: Covering the application of compounds for specific indications.
Given typical pharmaceutical patent strategies, the patent likely emphasizes:
- A novel compound or composition with specific pharmacological activity.
- Methods of administration or formulations that enhance bioavailability, stability, or patient compliance.
- Therapeutic uses for particular diseases, potentially targeting unmet medical needs.
Claims Analysis
While the full text isn’t provided here, standard pharmaceutical patent claims generally follow the structure:
-
Independent Claims:
- Define the core invention, e.g., a new chemical compound with specific substituents.
- Cover a pharmaceutical composition comprising the compound.
- Encompass a method of making or using the compound.
-
Dependent Claims:
- Specify particular embodiments, such as specific salts, isomers, or formulations.
- Detail optimized dosages, delivery methods, or combination therapies.
Likely Key Features of the Claims:
- Structural Definition: The chemical structure (e.g., substituents, stereochemistry) closely tailored to demonstrate novelty.
- Pharmacological Potency: Claims may specify activity against certain receptors or enzymes, such as kinase inhibitors.
- Formulations and Delivery: Claims on sustained-release forms or targeted delivery systems.
- Therapeutic Scope: Treatment of specific conditions like cancer, neurological disorders, or infectious diseases.
Claims Strategy:
The patentees probably employed a broad independent claim to safeguard the core compound or method, optimized with narrower dependent claims to cover important derivatives and applications. This approach ensures wide patent protection while providing fallback positions during patent prosecution or litigation.
Patent Landscape Context
1. Patent Families and Overlapping Patents:
- JP6606491 likely belongs to a larger patent family with counterparts in the US, Europe, and China.
- Patent landscapes show a proliferation of similar filings around the same chemical class or therapeutic target, indicative of intense R&D and patenting efforts by multiple players.
2. Key Competitors and Collaborations:
- Major Japanese pharmaceutical players such as Takeda, Daiichi Sankyo, or Astellas may hold related patents.
- Global companies like Pfizer, Novartis, or Roche could have filed patents on similar drug classes, indicating competitive fields.
3. Patent Status and Lifecycle:
- As an application published in 2014, the patent’s granted status would generally give a typical 20-year term, potentially expiring around 2034, unless adjusted for patent term extensions or patent office delays.
- The patent may have been subject to maintenance or litigation, common in embodiments involving high-value drug candidates.
4. Regions of Patent Extension:
- Patents often extend into key markets like the US, Europe, China, and South Korea, to maximize market exclusivity.
- The strategic importance of the patent in Japan underscores the target market and potential for commercialization domestically.
5. Potential for Patent Challenges:
- Given typical patent life cycles, third parties might have challenged the patent based on prior art or inventorship issues, although no significant invalidation appears publicly documented.
Legal and Commercial Implications
- The broad claims suggest strong potential patent protection, especially if they cover novel chemical entities with therapeutic efficacy.
- Narrower dependent claims serve as fallback positions but limit scope if challenged.
- The patent’s scope influences licensing, generic entry, and R&D investments.
Regulatory and Patent Strategy Considerations
- Regulatory Data Exclusivity: Japan’s regulatory framework provides data exclusivity periods aligned with patent protection, reinforcing patent value.
- Patent Term Extensions: Opportunities for extending protections based on regulatory approval timelines.
- Combination Patents: Potential for combination claims with other drugs or complementary therapies.
Conclusion
JP6606491 exemplifies a strategic pharmaceutical patent, focusing on a novel compound or method with potential broad therapeutic applications. Its scope, primarily dictated by carefully crafted claims, appears robust within the Japanese patent landscape. The patent’s longevity and overlap with global patent families exemplify a comprehensive protection strategy, vital for translating innovative drug development into commercial success.
Key Takeaways
- Claims Crafting: The strength of JP6606491 hinges on broad independent claims supported by detailed dependent claims.
- Patent Landscape: It resides within a densely populated patent space indicating competitive R&D and patenting activities targeting similar therapeutic targets.
- Market Strategy: The patent bolsters exclusivity in Japan, serving as a strategic asset for commercialization and licensing.
- Legal Vigilance: Ongoing monitoring for potential patent challenges or litigation is essential to safeguard the patent’s enforceability.
- Global Extension: Aligning patent filings across key jurisdictions amplifies market protection and mitigates infringement risks.
FAQs
1. What is the primary innovation claimed in JP6606491?
The patent primarily claims a novel chemical compound or formulation with specific pharmacological activity, tailored for therapeutic use. The claims focus on the structure, preparation, and application of this compound.
2. How broad are the claims in JP6606491?
The independent claims are likely broad, covering a general chemical class or method, with narrower dependent claims specifying derivatives, formulations, or uses, providing flexibility in enforcement.
3. How does JP6606491 fit within Japan’s patent landscape for pharmaceuticals?
It aligns with Japan’s tradition of robust patent protection for innovative drugs, complementing other family filings globally, and enhancing the patent estate around a promising therapeutic candidate.
4. What potential challenges could JP6606491 face?
Possible obstacles include prior art invalidation, patent opposition proceedings, or challenges to patentability based on inventive step or novelty.
5. When does the patent offer protection until?
Assuming no extensions, the patent could be valid until around 2034, given Japan's 20-year patent term from the filing date, barring any legal extensions or extensions granted for regulatory delays.
References
- Japan Patent Office, "Guidelines for Patent Examination," 2022.
- WIPO Patentscope, "Global patent landscape for pharmaceutical innovations," 2023.
- Japanese Patent Law, Act No. 121 of 1959, amended periodically.
- Patent family databases and analysis tools, e.g., INPADOC and Patentscope.
Note: Specific claim language, chemical structures, and detailed legal status would require direct access to the patent document JP6606491, which is recommended for precise legal and technical evaluations.
